Evidence map›Paper›PMID 35494766›Full record

ReviewRSC advances2021

Anti-bacterial activity of gold nanocomposites as a new nanomaterial weapon to combat photogenic agents: recent advances and challenges.

Ahmad Mobed, Mohammad Hasanzadeh, Farzad Seidi

Abstract readReview
In one paragraph

Review in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Gold-Based Nanostructures for Antibacterial Application.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Nanoparticles: Taking a Unique Position in Medicine.Nanomaterials (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmad MobedAging Research Institute, Faculty of Medicine, Tabriz University of Medical Sciences Iran Mobeda@tbzmed.ac.ir.ORCID https://orcid.org/0000-0001-8939-3688
Mohammad HasanzadehPharmaceutical Analysis Recent Center, Tabriz University of Medical Sciences Tabriz Iran hasanzadehm@tbzmed.ac.ir.ORCID https://orcid.org/0000-0003-4918-1239
Farzad SeidiJiangsu Co-Innovation Center for Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, Nanjing Forestry University Nanjing 210037 China.ORCID https://orcid.org/0000-0001-5510-9554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gold nanocomposites are being widely used in numerous biomedical applications owing to their excellent stability and miniaturization. Gold nanocomposites are notable because of their flexibility of functionalization and synthesis, ease of detection, and low toxicity. Cost-effectiveness, long-term stability, non-cytotoxicity, and biocompatibility are the main aspects of ideal nanocomposites. Antibacterial nanocomposites are being developed extensively in the food industry, environmental applications, and biological and medical devices. This review focuses on the applications of metal-based nanoparticles, mainly gold nanoparticles (AuNPs), as antibacterial agents in medical approaches. Additionally, the antibacterial mechanisms of AuNPs and their roles in fighting antibiotic-resistant microorganisms are highlighted in the present review.

Identifiers

PMID35494766
PMCPMC9042813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.